Join to view full profile
6818 W Thunderbird RdPeoria, AZ 85381
Phone+1 623-209-7831
Fax+1 623-566-3573
Dr. Schechtman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cleveland Clinic FoundationResidency, Gastroenterology, 2019 - 2025- Cleveland Clinic FoundationFellowship, Rheumatology, 1983 - 1985
Ohio University Heritage College of Osteopathic Medicine in AthensClass of 1980
Certifications & Licensure
OH State License 1981 - 2028
AZ State License 1987 - 2027
IL State License 1985 - 1990
TN State License 1980 - 1989
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ChartLogic EMR, ChartLogic, a Division of Medsphere Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 2 Certification ChartLogic, ChartLogic, a Division of Medsphere Systems Corporation, 2011, 2013-2017
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
Publications & Presentations
PubMed
- 3 citationsEffectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional...Aaron Broadwell, Joy Schechtman, Douglas Conaway, Alan Kivitz, Natalie J Shiff
BMC Rheumatology. 2023-03-27 - 80 citationsSafety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene:...Philip J. Mease, Nathan Wei, Edward J. Fudman, Alan Kivitz, Joy Schechtman
The Journal of Rheumatology. 2010-04-01 - 156 citationsOcrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, d...Mark C. Genovese, Jeffrey L. Kaine, Mitchell B. Lowenstein, Jose Del Giudice, Andrew R. Baldassare
Arthritis and Rheumatism. 2008-09-01
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: